Join thousands of book lovers
Sign up to our newsletter and receive discounts and inspiration for your next reading experience.
By signing up, you agree to our Privacy Policy.You can, at any time, unsubscribe from our newsletters.
THE AHA CLINICAL SERIES ELLIOTT ANTMAN, MD, SERIES EDITOR The strategic driving force behind the American Heart Association's mission of healthier lives free of cardiovascular disease and stroke is to change practice by providing information and solutions to healthcare professionals.
Up-to-date information on CT and MRI for the clinician Comes at a time of dramatic changes in the cardiovascular imaging field Extends from summary of basic principles to advanced discussions Enables the clinician to best use the technology at hand.
Biomarkers in Heart Disease is the first title in the AHA Clinical Series and is aimed at meeting the needs of clinicians, providing cardiologists, internists, emergency physicians, laboratorians, and other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine.
This new reference guides physicians in the practical aspects of how to diagnose and treat patients with congenital heart disease.
THE AHA CLINICAL SERIES ELLIOTT ANTMAN, MD, SERIES EDITOR The strategic driving force behind the American Heart Association's mission of healthier lives free of cardiovascular disease and stroke is to change practice by providing information and solutions to healthcare professionals.
This book is part of the AHA Clinical Series published in conjunction with the American Heart Association in order to focus on high-interest and emerging topics in cardiovascular disease targeted for cardiologists and other interested healthcare providers.
Comprehensive and concise presentation of cardiovascular genetics and advancements in the field Summarizes broad areas of contemporary genomic medicine Discusses specific cardiovascular diseases and their genetic components Addresses emerging concepts in pharmacogenetics.
The relationship of metabolic diseases to cardiovascular disease (CVD) is reaching epidemic proportions. This relates mostly to the increasing prevalence of obesity, the metabolic syndrome and type 2 diabetes.
Sign up to our newsletter and receive discounts and inspiration for your next reading experience.
By signing up, you agree to our Privacy Policy.